This article was originally published on ETFTrends.com.
By Visual Capitalist via Iris.xyz.
The billion-dollar cannabis industry is reaching new heights. While stigma and restrictions still exist, these haven’t slowed the industry’s global growth, and it’s projected at almost $32 billion by 2022. At the core of it is a growing appreciation and understanding for cannabidiol, or CBD—a non-intoxicating compound found in cannabis and hemp plants. Today’s infographic from The Green Organic Dutchman wraps up our “Soil to Sale” series, by explaining CBD’s therapeutic benefits and why it’s taking the world by storm.
CBD: A Medical Marvel
CBD is one of two major cannabinoids that naturally occur in cannabis. It has a long history of being used medicinally, but it fell out of favor due to legal issues.
Today, it’s making a comeback. Medical cannabis relies on CBD for its therapeutic properties, and the personal anecdotes of patients are being increasingly backed by science. There are currently over 300 active and completed clinical trials concerning CBD, and it’s proven to help with a range of health issues, from simple to complex:
- Chronic pain
- Inflammation and arthritis
- Anxiety and depression
- Nausea or appetite loss
- Multiple sclerosis
- Crohn’s disease
- Epilepsy and seizures
The Food and Drug Administration (FDA) recently approved the first prescription CBD drug, Epidiolex, for its efficacy in reducing epilepsy seizures.
CBD is Going Global
It’s no wonder that over 20 countries have established medical cannabis markets, with more following suit. But there’s a catch—it can be legal to buy CBD-based products, but not cannabis. Ever-changing laws further complicate the legal status of CBD worldwide.
Read the full article at Iris.xyz.
POPULAR ARTICLES AND RESOURCES FROM ETFTRENDS.COM
- SPY ETF Quote
- VOO ETF Quote
- QQQ ETF Quote
- VTI ETF Quote
- JNUG ETF Quote
- Top 34 Gold ETFs
- Top 34 Oil ETFs
- Top 57 Financials ETFs
- Trump Trade Comments Drive Market Lower
- FlexShares Debuts Quality Low Volatility ETF Suite on NYSE
- Can Libra Save Facebook?
- Brooks Runs With American Flag Shoe
- JP Morgan Rolls Out Robo-Advisor Amidst Competition